|
IL10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38720035458562E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.65699999674385E-08 |
| Normal-vs-Stage2 |
5.980500E-04 |
| Normal-vs-Stage3 |
1.74429999999504E-06 |
| Normal-vs-Stage4 |
4.29170000004753E-06 |
| Stage1-vs-Stage2 |
9.042200E-01 |
| Stage1-vs-Stage3 |
7.727400E-01 |
| Stage1-vs-Stage4 |
5.720200E-01 |
| Stage2-vs-Stage3 |
7.364400E-01 |
| Stage2-vs-Stage4 |
7.374800E-01 |
| Stage3-vs-Stage4 |
4.139200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.6107005446363E-11 |
| Normal-vs-AfricanAmerican |
1.045400E-01 |
| Normal-vs-Asian |
2.968300E-02 |
| Caucasian-vs-AfricanAmerican |
4.345200E-01 |
| Caucasian-vs-Asian |
7.704000E-01 |
| AfricanAmerican-vs-Asian |
8.165200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.23339960046121E-10 |
| Normal-vs-Female |
7.54360000021492E-07 |
| Male-vs-Female |
5.732200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.873900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.25559995523395E-09 |
| Normal-vs-Age(61-80Yrs) |
5.09490000188961E-08 |
| Normal-vs-Age(81-100Yrs) |
3.021700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.996200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.317200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.865400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.567400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.601800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.522200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.145900E-02 |
| Normal-vs-Grade 2 |
7.76090000043084E-08 |
| Normal-vs-Grade 3 |
1.42390000013037E-07 |
| Normal-vs-Grade 4 |
2.61189999961609E-07 |
| Grade 1-vs-Grade 2 |
4.412000E-01 |
| Grade 1-vs-Grade 3 |
4.792600E-01 |
| Grade 1-vs-Grade 4 |
1.491240E-01 |
| Grade 2-vs-Grade 3 |
4.183200E-01 |
| Grade 2-vs-Grade 4 |
2.551600E-01 |
| Grade 3-vs-Grade 4 |
3.912000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.21249999998729E-06 |
| Normal-vs-ccB subtype |
2.24260054970671E-10 |
| ccA subtype-vs-ccB subtype |
1.351560E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.49990003645217E-09 |
| Normal-vs-N1 |
5.440300E-02 |
| N0-vs-N1 |
6.014000E-01 |
|
|
